Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Boston Scientific Corpora...

    NYSE: BSX · Real-Time Price · USD
    101.94
    -0.89 (-0.87%)
    At close: Jun 06, 2025, 3:06 PM

    Boston Scientific Statistics

    Share Statistics

    Boston Scientific has 1.48B shares outstanding. The number of shares has increased by 0.6% in one year.

    Shares Outstanding

    n/a
    		 1.48B

    Shares Change (YoY)

    n/a
    		 0.6%

    Shares Change (QoQ)

    n/a
    		 0.36%

    Owned by Institutions (%)

    n/a
    		 90.6%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 6,868

    FTD / Avg. Volume

    n/a
    		 0.08%

    Short Selling Information

    The latest short interest is 16.75M, so 1.13% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 16.75M

    Short % of Shares Out

    n/a
    		 1.13%

    Short % of Float

    n/a
    		 1.13%

    Short Ratio (days to cover)

    n/a
    		 2.77

    Valuation Ratios

    The PE ratio is 70.89 and the forward PE ratio is 31.13. Boston Scientific's PEG ratio is 4.25.

    PE Ratio

    n/a
    		 70.89

    Forward PE

    n/a
    		 31.13

    PS Ratio

    n/a
    		 7.85

    Forward PS

    n/a
    		 5.5

    PB Ratio

    n/a
    		 6.04

    P/FCF Ratio

    n/a
    		 49.69

    PEG Ratio

    n/a
    		 4.25
    Financial Ratio History

    Enterprise Valuation

    Boston Scientific has an Enterprise Value (EV) of 142.17B.

    EV / Sales

    n/a
    		 8.49

    EV / EBITDA

    n/a
    		 36.08

    EV / EBIT

    n/a
    		 41.39

    EV / FCF

    n/a
    		 53.75

    Financial Position

    The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.51.

    Current Ratio

    n/a
    		 1.08

    Quick Ratio

    n/a
    		 0.64

    Debt / Equity

    n/a
    		 0.51

    Debt / EBITDA

    n/a
    		 2.83

    Debt / FCF

    n/a
    		 4.21

    Interest Coverage

    n/a
    		 8.53

    Financial Efficiency

    Return on Equity is 8.52% and Return on Invested Capital is 6.06%.

    Return on Equity

    n/a
    		 8.52%

    Return on Assets

    n/a
    		 4.71%

    Return on Invested Capital

    n/a
    		 6.06%

    Revenue Per Employee

    n/a
    		 $315,981.13

    Profits Per Employee

    n/a
    		 $34,981.13

    Employee Count

    n/a
    		 53,000

    Asset Turnover

    n/a
    		 0.43

    Inventory Turnover

    n/a
    		 1.87

    Taxes

    Income Tax

    n/a
    		 436M

    Effective Tax Rate

    n/a
    		 19.11%

    Stock Price Statistics

    The stock price has increased by 34.88% in the last 52 weeks. The beta is 0.69, so Boston Scientific's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.69

    52-Week Price Change

    n/a
    		 34.88%

    50-Day Moving Average

    n/a
    		 100.84

    200-Day Moving Average

    n/a
    		 93.85

    Relative Strength Index (RSI)

    n/a
    		 47.87

    Average Volume (20 Days)

    n/a
    		 8,345,371

    Income Statement

    In the last 12 months, Boston Scientific had revenue of 16.75B and earned 1.85B in profits. Earnings per share was 1.26.

    Revenue

    n/a
    		 16.75B

    Gross Profit

    n/a
    		 11.49B

    Operating Income

    n/a
    		 2.6B

    Net Income

    n/a
    		 1.85B

    EBITDA

    n/a
    		 3.94B

    EBIT

    n/a
    		 2.59B

    Earnings Per Share (EPS)

    n/a
    		 1.26
    Full Income Statement

    Balance Sheet

    The company has 414M in cash and 11.15B in debt, giving a net cash position of -10.73B.

    Cash & Cash Equivalents

    n/a
    		 414M

    Total Debt

    n/a
    		 11.15B

    Net Cash

    n/a
    		 -10.73B

    Retained Earnings

    n/a
    		 2.67B

    Total Assets

    n/a
    		 40.14B

    Working Capital

    n/a
    		 2.28B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 3.44B and capital expenditures -790M, giving a free cash flow of 2.65B.

    Operating Cash Flow

    n/a
    		 3.44B

    Capital Expenditures

    n/a
    		 -790M

    Free Cash Flow

    n/a
    		 2.65B

    FCF Per Share

    n/a
    		 1.8
    Full Cash Flow Statement

    Margins

    Gross margin is 68.61%, with operating and profit margins of 15.54% and 11.07%.

    Gross Margin

    n/a
    		 68.61%

    Operating Margin

    n/a
    		 15.54%

    Pretax Margin

    n/a
    		 13.63%

    Profit Margin

    n/a
    		 11.07%

    EBITDA Margin

    n/a
    		 23.53%

    EBIT Margin

    n/a
    		 15.54%

    FCF Margin

    n/a
    		 15.79%

    Dividends & Yields

    BSX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 1.41%

    FCF Yield

    n/a
    		 2.01%
    Dividend Details

    Analyst Forecast

    The average price target for BSX is $117, which is 14% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $117

    Price Target Difference

    n/a
    		 14%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 21
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 20.48

    Graham Upside

    n/a
    		 -80.05%

    Stock Splits

    The last stock split was on Nov 6, 2003. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Nov 6, 2003

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 6.1

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist